DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,755 filers reported holding DANAHER CORPORATION in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $159,068,000 | +3.2% | 716,070 | +0.1% | 0.47% | -9.6% |
| Q3 2020 | $154,110,000 | +27.2% | 715,690 | +4.4% | 0.52% | +16.3% |
| Q2 2020 | $121,203,000 | +23.8% | 685,424 | -3.1% | 0.45% | +3.5% |
| Q1 2020 | $97,926,000 | -4.9% | 707,510 | +5.5% | 0.43% | +17.0% |
| Q4 2019 | $102,922,000 | +6.1% | 670,590 | -0.2% | 0.37% | -3.6% |
| Q3 2019 | $97,045,000 | +5.5% | 671,917 | +4.4% | 0.38% | +2.1% |
| Q2 2019 | $91,973,000 | +13.8% | 643,531 | +5.1% | 0.38% | +7.7% |
| Q1 2019 | $80,802,000 | +32.4% | 612,046 | +3.4% | 0.35% | +13.3% |
| Q4 2018 | $61,034,000 | -4.1% | 591,872 | +1.0% | 0.31% | +9.6% |
| Q3 2018 | $63,667,000 | +9.8% | 585,925 | -0.2% | 0.28% | +1.4% |
| Q2 2018 | $57,961,000 | +2.6% | 587,363 | +1.8% | 0.28% | -1.4% |
| Q1 2018 | $56,495,000 | +14.9% | 577,015 | +9.0% | 0.28% | +12.4% |
| Q4 2017 | $49,150,000 | +12.6% | 529,517 | +4.1% | 0.25% | +1.6% |
| Q3 2017 | $43,644,000 | +8.7% | 508,789 | +6.9% | 0.25% | 0.0% |
| Q2 2017 | $40,164,000 | +4.4% | 475,929 | +5.9% | 0.25% | -6.5% |
| Q1 2017 | $38,453,000 | +15.0% | 449,588 | +4.7% | 0.26% | +2.7% |
| Q4 2016 | $33,424,000 | -5.7% | 429,389 | -5.0% | 0.26% | -0.4% |
| Q3 2016 | $35,442,000 | +9.9% | 452,125 | +41.7% | 0.26% | +2.0% |
| Q2 2016 | $32,237,000 | +16.8% | 319,176 | +9.7% | 0.25% | +6.8% |
| Q1 2016 | $27,596,000 | +3.8% | 290,913 | +1.7% | 0.24% | -2.9% |
| Q4 2015 | $26,579,000 | +19.2% | 286,165 | +9.4% | 0.24% | +7.0% |
| Q3 2015 | $22,298,000 | +15.0% | 261,679 | +15.5% | 0.23% | +13.5% |
| Q2 2015 | $19,391,000 | +14.5% | 226,561 | +13.6% | 0.20% | +5.3% |
| Q1 2015 | $16,931,000 | +7.6% | 199,425 | +8.6% | 0.19% | -2.1% |
| Q4 2014 | $15,734,000 | +20.2% | 183,576 | +6.5% | 0.19% | +9.6% |
| Q3 2014 | $13,092,000 | +3.2% | 172,314 | +7.0% | 0.18% | -3.8% |
| Q2 2014 | $12,681,000 | +9.5% | 161,067 | +4.3% | 0.18% | +12.9% |
| Q1 2014 | $11,583,000 | +1.7% | 154,437 | +4.7% | 0.16% | -7.9% |
| Q4 2013 | $11,392,000 | +23.0% | 147,565 | +10.4% | 0.18% | -1.1% |
| Q3 2013 | $9,262,000 | +24.1% | 133,607 | +13.3% | 0.18% | +1.1% |
| Q2 2013 | $7,466,000 | – | 117,941 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |